Gemifloxacin: Survival of the fittest

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue TOPIC T1, 2000, Pages 33-37

  Mandell, Lionel ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; GEMIFLOXACIN; MACROLIDE; PENICILLIN G; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ARTICLE; CHRONIC BRONCHITIS; CONTROLLED STUDY; DISEASE EXACERBATION; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; PNEUMONIA; PRESCRIPTION; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIA; UNITED STATES;

EID: 0033910453     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jac.a020892     Document Type: Article

References (35)

1. Gould, S. J. (1994). The evolution of life on the earth. Scientific American 271, 84-91.
2. Ball, P. (1998).The quinolones: History and overview. In The Quinolones, 2nd edn, (Andriole, V. T., Ed.), pp. 1-28. Academic Press, San Diego.
3. Mandell, L. A. & Niederman, M. (1993). The Canadian community-acquired pneumonia consensus conference group: antimicrobial treatment of community-acquired pneumonia in adults. A conference report. Canadian Journal of Infectious Diseases 4, 25-8.
4. Niederman, M. A., Bass, J. B., Jr, Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A. et al. (1993). Guidelines for the initial management of adults with community-acquired pneumonia, diagnosis, assessment of severity, and initial antimicrobial therapy. American Review of Respiratory Disease 148, 1418-26.
5. Bartlett, J. G., Breiman, R. F., Mandell, L. A. & File, T. M., Jr (1998). Community-acquired pneumonia in adults: guidelines for management. Clinical Infectious Diseases 26, 811-38.
6. Marston, B. J., Plouffe, J. F., File, T. M., Jr, Hackman, B. A., Salstrom, S. J. & Lipman, H. B. (1997). Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Archives of Internal Medicine 157, 1709-18.
7. Troy, C. J., Peeling, R. W., Ellis, A. G., Hockin, J. C., Bennett, D. A., Murphy, M. R. et al. (1997). Chlamydia pneumonia as a new source of infectious outbreaks in nursing homes. Journal of the American Medical Association 277, 1214-8.
8. Friedland, I. R. & McCracken, G. H., Jr (1994). Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New England Journal of Medicine 331, 377-82.
9. Rahav, G., Toledano, Y., Engelhard, D., Simhon, A., Moses, A. E., Sacks, T. et al. (1997). Invasive pneumococcal infections: a comparison between adults and children. Medicine 76, 295-303.
10. Hansman, D. & Bullen, M. M. (1967). A resistant pneumococcus. Lancet ii, 264.
11. Naraqi, S., Kirkpatrick, G. P. & Kabins, S. (1974). Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. Journal of Pediatrics 85, 671-3.
12. Lapointe, J. & Joncas, J. H. (1983). Meningitis in a Canadian infant due to pneumococcus resistant to penicillin and chloramphenicol. Journal of Pediatrics 103, 580-2.
13. National Committee for Clinical Laboratory Standards. (1994). Performance Standards for Antimicrobial Susceptibility Testing -Document M100-S5. NCCLS, Villanova, PA.
14. Ballow, C. H., Jones, R. N., Johnson, D., Deinhart, J. A., Schentag, J. & the SPAR Study Group. (1997). Regional trends in S. pneumoniae resistance: results of a nationwide, multi-center trial. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 1997. Abstract E-118, p. 135.
15. Thornsberry, C., Ogilvie, P., Kahn, J. B. & Mauriz, Y. (1997). Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagnostic Microbiology and Infectious Disease 29, 249-57.
16. Johnston, N. J., deAzavedo, J. C., Kellner, J. D. & Low, D. E. (1997). Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in Streptococcus pneumoniae from across Canada. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 1997. Abstract C-77a, p. 59.
17. Kohler, T. & Pechere, J. C. (1998). Bacterial resistance to quinolones. In The Quinolones, 2nd edn, (Andriole, V. T., Ed.), pp. 117-42. Academic Press, San Diego.
18. Wise, R., Brenwald, N., Gill, M. & Fraise, A. (1996). Streptococcus pneumoniae resistance to fluoroquinolones. Lancet 348, 1660.
19. Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I. et al. (1978). Emergence of multiply resistant pneumococci. New England Journal of Medicine 299, 735-40.
20. McDougal, L. K., Facklam, R., Reeves, M., Hunter, S., Swenson, J. M., Hill, B. C. et al. (1992). Analysis of multiple antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrobial Agents and Chemotherapy 36, 2176-84.
21. Doern, G. V., Brueggemann, A., Holley, H. P., Jr & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from out-patients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 1208-13.
22. Plouffe, J. F., Breiman, R. F. & Facklam, R. R. (1996). Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study group. Journal of the American Medical Association 275, 194.
23. Einarsson, S., Kristjansson, M., Kristinsson, K., Kjartansson, G. & Jonsson, S. (1998). Pneumonia cause by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study. Scandinavian Journal of Infectious Diseases 30, 253-6.
24. Pallares, R., Linares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F. et al. (1995). Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. New England Journal of Medicine 333, 474-80.
25. Friedland, I. R. (1995). Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatric Infectious Diseases 14, 885-90.
26. Friedland, I. R. & Klugman, K. P. (1992). Antibiotic-resistant pneumococcal disease in South African children. American Journal of Diseases of Children 146, 920-3.
27. Low, D. E. (1998). Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus and gram-negative rods. Infectious Disease Clinics of North America 12, 613-30.
28. Craig, W. A. (1996). Antimicrobial resistance issues of the future. Diagnostic Microbiology and Infectious Disease 25, 213-7.
29. Goldstein, F. W. (1997). Choice of an oral β-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae. Scandinavian Journal of Infectious Diseases 29, 255-7.
30. Dixon, R. E. (1985). Economic costs of respiratory tract infections in the United States. American Journal of Medicine 78, 45-51.
31. Graves, E. J. (1992). Detailed diagnosis and procedures, national hospital discharge survey, 1990. Vital Health Statistics 13 1-225.
32. ERS Task Force Report. (1998). Guidelines for management of adult community-acquired lower respiratory tract infection. European Respiratory Journal 11, 986-91.
33. Niroumand, M. & Grossman, R. F. (1998). Airway Infection. Infectious Disease Clinics of North America 12, 671-88.
34. Balter, M. S., Hyland, R. H., Low, D. E. & Renzi, P. M. (1994). Recommendations on the management of chronic bronchitis. Canadian Medical Association Journal 151, Suppl., 7-23.
35. Grossman, R. F., Mukerjee, J., Vaughan, D., Eastwood, C., Cook, R., LaForge, J. et al. (1998). A one-year community based health economic study of ciprofloxacin versus usual antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 113, 131-41.